These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2459936)

  • 21. Optical spectral studies of ebselen interaction with cytochrome P-450 of rat liver microsomes.
    Kühn-Velten N; Sies H
    Biochem Pharmacol; 1989 Feb; 38(4):619-25. PubMed ID: 2917017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of leukotriene B4 formation by Ebselen: a novel approach to antiinflammatory therapy.
    Kuhl P; Borbe HO; Römer A; Fischer H; Parnham MJ
    Agents Actions; 1986 Jan; 17(3-4):366-7. PubMed ID: 3008531
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of the reaction of ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen.
    Haenen GR; De Rooij BM; Vermeulen NP; Bast A
    Mol Pharmacol; 1990 Mar; 37(3):412-22. PubMed ID: 2107391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of superoxide anion radical production by ebselen (PZ51) and its sulfur analogue (PZ25) in guinea pig alveolar macrophages.
    Leurs R; Timmerman H; Bast A
    Biochem Int; 1989 Feb; 18(2):295-9. PubMed ID: 2548505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ebselen inhibits contractile responses of guinea-pig parenchymal lung strips.
    Leurs R; Bast A; Timmerman H
    Eur J Pharmacol; 1990 Apr; 179(1-2):193-9. PubMed ID: 2114294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of ebselen on polymorphonuclear leukocyte and lymphocyte migration to inflammatory reactions in rats.
    Gao JX; Issekutz AC
    Immunopharmacology; 1993; 25(3):239-51. PubMed ID: 8354640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno-organic compound, ebselen.
    Ichikawa S; Omura K; Katayama T; Okamura N; Ohtsuka T; Ishibashi S; Masayasu H
    J Pharmacobiodyn; 1987 Oct; 10(10):595-7. PubMed ID: 2831335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual effect of ebselen on mitochondrial permeability transition.
    Morin D; Zini R; Ligeret H; Neckameyer W; Labidalle S; Tillement JP
    Biochem Pharmacol; 2003 May; 65(10):1643-51. PubMed ID: 12754100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice.
    Wendel A; Tiegs G
    Biochem Pharmacol; 1986 Jul; 35(13):2115-8. PubMed ID: 3729968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression.
    Lindenblatt N; Schareck W; Belusa L; Nickels RM; Menger MD; Vollmar B
    Thromb Haemost; 2003 Nov; 90(5):882-92. PubMed ID: 14597984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ebselen as a peroxynitrite scavenger in vitro and ex vivo.
    Daiber A; Zou MH; Bachschmid M; Ullrich V
    Biochem Pharmacol; 2000 Jan; 59(2):153-60. PubMed ID: 10810449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some aspects of cardiac antioxidant defence: Ebselen (PZ 51) treatment increases glutathione peroxidase activity in the rat heart.
    Hermenegildo C; Nies E; Monsalve E; Puertas FJ; Higueras V; Romero FJ
    Biochem Soc Trans; 1990 Dec; 18(6):1193-4. PubMed ID: 2088859
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel biologically active seleno-organic compound--III. Effects of PZ 51 (Ebselen) on glutathione peroxidase and secretory activities of mouse macrophages.
    Parnham MJ; Kindt S
    Biochem Pharmacol; 1984 Oct; 33(20):3247-50. PubMed ID: 6593071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect of ebselen on compound 48/80- and anti-IgE-induced histamine release from rat peritoneal mast cells.
    Tchoumkeu-Nzouessa GC; Rebel G
    Biochem Pharmacol; 1998 Dec; 56(11):1525-8. PubMed ID: 9827587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisecretory and antiulcer effects of ebselen, a seleno-organic compound, in rats.
    Tabuchi Y; Kurebayashi Y
    Jpn J Pharmacol; 1993 Mar; 61(3):255-7. PubMed ID: 8483303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of the anti-inflammatory seleno-organic compound ebselen with acid secretion in isolated parietal cells and gastric H+/K(+)-ATPase.
    Beil W; Staar U; Sewing KF
    Biochem Pharmacol; 1990 Nov; 40(9):1997-2003. PubMed ID: 2173597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions.
    Sarma BK; Mugesh G
    J Am Chem Soc; 2005 Aug; 127(32):11477-85. PubMed ID: 16089478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of preconditioning with ebselen on glutathione metabolism and stress protein expression.
    Hoshida S; Aoki K; Nishida M; Yamashita N; Igarashi J; Hori M; Kuzuya T; Tada M
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1471-5. PubMed ID: 9190885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacology of ebselen.
    Parnham MJ; Leyck S; Graf E; Dowling EJ; Blake DR
    Agents Actions; 1991 Jan; 32(1-2):4-9. PubMed ID: 2058468
    [No Abstract]   [Full Text] [Related]  

  • 40. Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
    Jpn J Pharmacol; 2002 Dec; 90(4):295-303. PubMed ID: 12501005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.